Streetbeat News

Stock Prices

REGN

A whale has taken a bullish stance on Regeneron Pharmaceuticals (NASDAQ: REGN) with unusual options activity detected. 50% of investors opened trades with bullish expectations and 50% with bearish. Whales have been targeting a price range of $700 to $900 for REGN over the last 3 months.

Portfolio Pulse from Benzinga Insights

May 25, 2023 | 8:19 pm

GROV

Grove Collaborative Holdings, Inc. (NYSE:GROV) has announced a 1-for-5 reverse stock split, effective after market close on June 5, 2023. The split is intended to increase the market price per share and help the company regain compliance with the NYSE minimum share price listing rule.

Portfolio Pulse from Happy Mohamed

May 25, 2023 | 8:17 pm

MRVL

Marvell Technology forecasts its AI revenue in fiscal 2024 to at least double from the prior year and continue to grow rapidly in the coming years.

Portfolio Pulse from Benzinga Newsdesk

May 25, 2023 | 8:14 pm

VIRI

Virios Therapeutics has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share, as its shares closed at or above the threshold for 10 consecutive business days.

Portfolio Pulse from Benzinga Newsdesk

May 25, 2023 | 8:13 pm

LABP

Landos Biopharma announced a 1-for-10 reverse stock split, effective May 26, 2023. The company's common stock will trade on a split-adjusted basis under the existing symbol 'LABP'.

Portfolio Pulse from Benzinga Newsdesk

May 25, 2023 | 8:11 pm

DECK

Deckers Brands forecasts FY24 net sales of approximately $3.95B, slightly below the consensus estimate of $3.97B, and EPS of $21.10-$21.60, lower than the consensus of $21.77.

Portfolio Pulse from Benzinga Newsdesk

May 25, 2023 | 8:10 pm

TCRX

TScan Therapeutics (NASDAQ:TCRX) has announced the launch of a proposed public offering of voting common stock, non-voting common stock, and pre-funded warrants. The offering is subject to market, regulatory, and other conditions. Morgan Stanley and Wedbush PacGrow are acting as joint book-running managers.

Portfolio Pulse from Happy Mohamed

May 25, 2023 | 8:09 pm

RH

RH reported Q1 earnings of $2.21 per share, beating the analyst consensus estimate of $2.09 by 5.74%. Quarterly sales were $739.16M, surpassing the estimate of $726.57M by 1.73%. However, this represents a 71.59% decrease in earnings and a 22.79% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 25, 2023 | 8:06 pm

WDAY

Workday (NASDAQ:WDAY) reported Q1 earnings with an EPS of $1.31, beating estimates by 16.96%. Revenue was up $249 million YoY. Last quarter, the company beat EPS estimates by $0.08, resulting in a 0.29% share price increase the next day.

Portfolio Pulse from Benzinga Insights

May 25, 2023 | 8:06 pm

ADSK

Autodesk (NASDAQ:ADSK) reported Q1 earnings with in-line EPS of $1.55 and revenue up $99 million YoY. Last quarter, the company beat EPS estimates by $0.05, followed by a 12.95% drop in share price the next day.

Portfolio Pulse from Benzinga Insights

May 25, 2023 | 8:06 pm